JiaJun Ye
Overview
Explore the profile of JiaJun Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ye J, Yang W, Xie Z, Yan Y, Li G, Li G, et al.
Mol Pharm
. 2023 Jan;
20(3):1750-1757.
PMID: 36668905
Coronavirus disease 2019 (COVID-19) is a serious threat to public health and is in urgent need of specific drugs. Meplazumab, a humanized monoclonal antibody targeting CD147, was confirmed to competitively...
12.
Kang C, Liu X, Xiang M, Yang J, Xiao Y, Ren B, et al.
Orthop Surg
. 2023 Jan;
15(8):1983-1989.
PMID: 36597676
Objective: Studies on extremely severe elbow stiffness after chronic dislocation in children are scarce. This study aims to investigate the choice of surgical treatment modalities and to analyze their treatment...
13.
Peng Y, Ye J, Xu Y, Huang J, Wu Y, Liu W, et al.
Front Cardiovasc Med
. 2022 Dec;
9:1048795.
PMID: 36465446
Objective: Coronary artery fistula, defined as communication between a coronary artery and a great vessel or a cardiac chamber, is a relatively rare anomaly with an estimated incidence of 0.002%...
14.
Zhang M, Ye J, Xie Z, Wang Y, Ma W, Kang F, et al.
Mol Pharm
. 2022 Mar;
19(5):1548-1556.
PMID: 35357154
High and sustained renal radioactivity accumulation is a major challenge in peptide-based radionuclide imaging and therapy. However, neutral endopeptidase (NEP)-based enzymatic hydrolysis to release and excrete the radioactive fragments has...
15.
Tang J, Wang L, Luo J, Xi D, Huang W, Yang S, et al.
Ann Palliat Med
. 2021 Nov;
10(10):10697-10705.
PMID: 34763430
Background: Hypoalbuminemia is a significant risk factor of cardiovascular disease and all-cause death in patients undergoing conventional hemodialysis (HD). However, the albumin (ALB) level of these dialysis patients runs through...
16.
Wu H, Chen Z, Qi S, Bai B, Ye J, Wu D, et al.
J Nanobiotechnology
. 2021 Oct;
19(1):330.
PMID: 34670552
Background: Supramolecular theranostics have exhibited promising potentials in disease diagnosis and therapy by taking advantages of the dynamic and reversible nature of non-covalent interactions. It is extremely important to figure...
17.
Zhao Y, Ye J, Zhou J
J Clean Prod
. 2021 Sep;
317:128361.
PMID: 34511741
The onset of 2020 is marked by stricter restrictions on maritime sulfur emissions and the spread of Coronavirus Disease 2019 (COVID-19). In this background, liner companies now face the challenge...
18.
Zhang M, Ye J, Xie Z, Yan Y, Wang J, Chen X
Bioconjug Chem
. 2021 Sep;
32(9):2108-2116.
PMID: 34486879
The kidney is the main dose-limiting organ in radioligand therapy (RLT), and there is an urgent need for reducing renal radioactivity accumulation. According to the enzymolysis clearance strategy, the first...
19.
Zhang Z, Wang X, Ye J, Liu H, Fang J, Zhang M, et al.
Mol Pharm
. 2021 Aug;
18(9):3509-3518.
PMID: 34410132
Although KRAS has been an important target for many cancers, direct inhibition of oncogenic RAS remains challenging. Until recently, covalent KRAS G12C-specific inhibitors have been developed and progressed to the...
20.
Zhang W, Ning N, Li X, Li M, Duan X, Guo Y, et al.
Neuroreport
. 2019 Jul;
30(11):776-782.
PMID: 31261240
Objectives: There are subclinical neurologic deficits in cirrhotic patients without overt hepatic encephalopathy. We aimed to use F-fluorodeoxyglucose PET/computed tomography to explore the impaired brain glucose metabolism of subclinical hepatic...